Resumen

MAIMI, Pablo Amair  y  RODULFO, Ildefonzo Arocha. Cardiorenal continuum: A proposal for the prevention of cardiovascular and renal disease. Rev. colom. nefrol. [online]. 2020, vol.7, n.1, pp.60-69.  Epub 09-Dic-2020. ISSN 2500-5006.  https://doi.org/10.22265/acnef.7.1.356.

Cardiovascular risk factors such as arterial hypertension, type 2 diabetes mellitus (DM2) and dyslipidemia are commonly involved with chronic kidney disease (CKD) and its contribution to long-term cardiovascular morbidity. Diffuse endothelial dysfunction and atherosclerosis are believed to be part of the common pathophysiology in diabetic and non-diabetic CKD, particularly in the elderly. Age is the main determinant of glomerular filtration rate (GFR) and effective renal plasma flow and has been reported that the presence of hypertension at baseline enhances the yearly decline in creatinine clearance. Dyslipidemia may directly affect the kidney by causing deleterious renal lipid disturbances (renal lipotoxicity), as well as indirectly through systemic inflammation and oxidative stress, vascular injury, hormones change and other signaling molecules with renal action. Several cross-sectional studies found that impaired glucose tolerance, as well as the presence of left ventricular hypertrophy, was associated with an increase in the slope of the inverse relationship between age and GFR in subjects with never-treated essential hypertension. Most of the drugs used to reduce the burden of risk factor on cardiovascular disease also benefit the renal function. So, we propose the cardiorenal continuum as a preventive strategy to protect both organ and reduce the deleterious impact of the cardiovascular risk factor on the renal function considering both organs as a functional and physiopathological binomial.

Palabras clave : Cardiorenal continuum; cardiovascular disease; chronic kidney disease; albuminuria; risk factors; hypertension; dyslipidemia; diabetes.

        · resumen en Español     · texto en Español     · Español ( pdf )